The rise and fall of methicillin-resistant Staphylococcus aureus infections in HIV patients

Area of Science:

• Infectious Diseases
• HIV Medicine
• Epidemiology

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat, particularly to immunocompromised populations.
• Human Immunodeficiency Virus (HIV) infection alters immune status, potentially increasing susceptibility to infections like MRSA.
• Understanding MRSA incidence and risk factors in HIV patients is crucial for targeted prevention and treatment strategies.

Purpose of the Study:

• To determine the annual and weighted incidence of MRSA infections in a prospective cohort of HIV-positive individuals.
• To identify specific risk factors associated with MRSA acquisition in this patient group.
• To analyze trends in MRSA incidence over time within the HIV-infected population.

Main Methods:

• Prospective cohort study design involving HIV patients.
• Data collection on MRSA infections and relevant patient characteristics from 2002 to 2009.
• Calculation of annual and weighted incidence rates.
• Analysis of risk factors including demographics, CD4 cell counts, and antiretroviral therapy status.

Main Results:

• A total of 228 MRSA infections were identified in 167 patients over the study period.
• Higher MRSA incidence rates were observed in men who have sex with men (MSM) and intravenous drug users (IDUs).
• Lower CD4 cell counts, absence of antiretroviral therapy, and younger age were associated with increased MRSA risk.
• The annual incidence of MRSA peaked in 2007 and subsequently showed a declining trend.

Conclusions:

• Specific populations within the HIV cohort, including MSM, IDUs, and those with advanced immunosuppression, are at higher risk for MRSA infections.
• Antiretroviral therapy and improved immune status may play a role in reducing MRSA incidence.
• The observed decline in MRSA incidence since 2007 warrants further investigation into contributing factors and continued surveillance.